IP Verse

Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic Antibody - EP2206728

PATENT ANALYSIS

Patent Details

Grant Date
Oct 10, 2018
Company
REGENTS OF THE UNIVERSITY OF MINNESOTA
Oppositions

REGENERON PHARMACEUTICALS, INC.

More patents of Regents Of The University Of Minnesota

EP3294323

EP2861737

EP2206728

Want to monitor this patent?

Feel free to send us a message here and we will get back to you